Eculizumab (Genetical Recombination) 300mg 30mL/vial 30 cases,and 8 other contracts

2026-11-03

Official in charge of disbursement of the procuring entity : NODE Koichi, President, National University Corporation Saga University Classification of the products to be procured : Nature and quantity of the products to be purchased : A Eculizumab (Genetical Recombination) 300mg 30mL/vial 3 cases B Nusinersen sodium 12mg 5mL/vial cases C Idursulfase beta (Genetical Recombi-nation) 15mg1mL/vial 2 cases D Ravulizumab (Genetical Recombination) 300mg 3mL/vial 8 cases E Ravulizumab (Genetical Recombination) 1100mg 11mL/vial 1 cases F Onasemnogene abeparvove 1patient Sets G Faricimab (Genetical Recombination) 120mg/mL 0.24mL×1vial 26 cases H Cetuximab sarotalocan sodium (Genetical Recombination) 250mg 50mL/vial 2 cases I Lisocabtagene maraleucel 1patient Set Delivery period : From April, 202 through 3 March, 202 Delivery place : Saga University Hospital Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : A not come under Article and of the Regulation concerning the Contract for Saga University Furthermore, minors, Person under Conservatorshi or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause B have the Grade A, Grade B or Grade C qualification during fiscal 202 in the Kyushu・Okinawa area in sales of product for participating in tenders by Single qualification for every ministry and agency, or in tenders by National University Corporation Saga University, C prove to have obtained the first-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices, D meet the qualification requirements which President may specify in accordance with Article of the Regulation E not be currently under a suspension of business order as instructed by President Time limit of tender : 1 : 0 1 March, 202 Contact point for the notice : KUBOI Ryou, Management and Control Division, Administration, Faculty of Medicine, Saga University, 5-1- Nabeshima Saga-shi 849-850 Japan, TEL 0952-34-311 E-Mail keieibut@mail.admin.saga-u.ac.j ⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.

Japan

2026-03-26